Overview

Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis

Status:
Terminated
Trial end date:
2018-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether hyperbaric oxygen therapy is effective in the treatment of osteoradionecrosis (late damage after radiotherapy) of the jaw.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Radboud University
Treatments:
Coal Tar
Criteria
Inclusion Criteria:

- Informed consent

- Age ≥ 18 jr

- WHO performance status 0-2

- Last radiation treatment ≥ 6 month ago radiotherapy with curative intention and > 55
Gy. The affected part of the jaw must be in the target volume area of the radiotherapy
field.

- Local recurrence must be ruled out

- Necrosis of the jaw with at least one of the following symptoms for over 3 month
present:

- Bone exposition which measures at least 1 cm

- Evident bone lesions at radiologic evaluation (panorex) that fits the diagnosis
ORN.

- Non-healing extraction socket

Exclusion Criteria:

- Former HBO treatment

- Contra indication for HBO treatment (pneumothorax)

- Bisphosphonate treatment in the medical history

- reirradiation in the medical history

- Osteosynthesis material in the affected area

- Distant metastasis

- Primary or recurrent tumor in the affected area

- Malignancies elsewhere